Biopol Chemicals IPO allotment is expected to be finalised today on February 11, 2026, with a tentative listing date fixed as February 13, 2026. Biopol Chemicals launched its SME IPO on February 06, 2026 with an issue size of ₹31.26 crores. The bidding window was open till yesterday, i.e, February 10, 2026 for public subscription. The shares of the company will be listed on the NSE SME platform.

Biopol Chemicals Limited operates in the trading, manufacturing, and distribution of specialty chemicals, offering products across silicones, emulsifiers, biochemicals, and polyelectrolytes. Its portfolio consists of 66 products—40 silicone-based, 5 emulsifier-based, 15 biochemical, and 6 polyelectrolyte products. These solutions cater to a wide range of applications, including textile processing (softeners, emulsions, and hardeners), home care (silicone fluids and cleaning agents), agriculture (silicone adjuvants and surfactants), and industrial chemicals (release agents).

Know the procedure to check Biopol Chemicals IPO allotment status online on the NSE, and the registrar’s website.

Procedure to Check Biopol Chemicals IPO Allotment Status Online On NSE

Visit the NSE’s IPO allotment verification status page here.
Select “Equity & SME IPO bid details”.
In Select Symbol, select “Biopol Chemicals Ltd”.
Enter your PAN No. and application No.
Click “Submit”.

Procedure to Check Biopol Chemicals IPO Allotment Status on Bigshare Services Limited (Registrar to the issue)

Visit the Bigshare Services IPO allotment status page here.
Click any of the server links.
In Company Selection, select “Biopol Chemicals Ltd”.
Enter either your application number, beneficiary ID or PAN.
Enter the captcha and click “Search”.

Biopol Chemicals IPO Details

The Biopol Chemicals IPO was a book build issue of ₹31.26 crores and was entirely a fresh issue of 0.29 crore shares. The price band was set between ₹102 and ₹108 per share, with a lot size of 1200 shares, requiring a minimum investment of ₹2,44,800 for retail investors.

Smart Horizon Capital Advisors Private Limited (Formerly Known as Shreni Capital Advisors Private

Limited) was the book running lead manager and Bigshare Services Pvt.Ltd. was the registrar of the issue. The Market Maker of the company was Shreni Shares Ltd.

Biopol Chemicals IPO Overall Subscription Status

[February 10, 2026, end of the day]

On Day 3, Biopol Chemicals IPO saw an overall subscription of 22.33 times. The public issue was subscribed 20.80 times by the Retail Individual Investors (RIIs), 24.49 times by the Non Institutional Investors (NIIs), and 21.05 times by the Qualified Institutional Buyers (QIBs).

Explore other Upcoming IPOs on BSE and NSE.

Utilisation of Proceeds

The Company proposes to utilise the Net Proceeds towards funding the following objects:

Acquisition of industrial land.
Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies.
General corporate purposes.

Biopol Chemicals Ltd GMP

As per media reports, the Grey Market Premium (GMP) of Biopol Chemicals Ltd is reported at ₹4 over the IPO price.

Check out newly Listed IPOs on BSE and NSE.

Biopol Chemicals Ltd Business Overview

Biopol Chemicals Ltd is an Ahmedabad, Gujarat-based specialty chemicals manufacturer incorporated in April 2023. The company is engaged in the manufacturing, trading and distribution of specialty chemical products including silicones, emulsifiers, biochemicals and polyelectrolytes, which serve industrial sectors such as textiles, home care, agriculture and industrial chemicals. It operates a Business-to-Business (B2B) model supplying institutional and industrial customers, and also provides technical consultancy services related to chemical applications and formulations.

Biopol’s product portfolio comprises around 66 specialty chemical products, including 40 silicone-based variants, 5 emulsifiers, 15 biochemical products and 6 polyelectrolytes. It operates manufacturing and distribution facilities in Gujarat and West Bengal, with a combined installed capacity of approximately 18.25 lakh litres per annum.

In FY25 (year ended March 31, 2025), Biopol Chemicals reported revenue from operations of about ₹49.1 crore, nearly doubling from around ₹25.4 crore in FY24. Its profit after tax (PAT) for FY25 stood at around ₹4.3 crore, up from about ₹3.0 crore in FY24, while EBITDA increased to approximately ₹6.5 crore.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.

Do you like this edition?